Literature DB >> 32654013

New approach to second metacarpophalangeal joint dislocation management: the SKY needling technique.

Sandeep Kumar Yadav1, Buddhadeb Nayak2, Sameer Mittal1.   

Abstract

Second metacarpophalangeal dislocation is a rare entity, wherein correct diagnosis can be achieved by careful and experienced clinical examination that must be followed by radiological examination. This mostly requires open reduction either by dorsal or volar approach. Open reduction by volar approach is being used most widely but has more incidence of postoperative loss of sensation at volar aspect of finger due to neurovascular injury (digital nerve and vessel) and also required more extensive dissection. Dorsal approach is a rather safe alternative to volar approach as it provides better exposure to volar plate. We present a new technique wherein the chances of neurovascular injury are very rare and make it an effective and less complicated surgery.

Entities:  

Keywords:  Dislocation; Metacarpals; Orthopedic; Volar plate

Mesh:

Year:  2020        PMID: 32654013     DOI: 10.1007/s00590-020-02728-w

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  4 in total

Review 1.  Ipsilateral complex dorsal dislocations of the index and long finger metacarpophalangeal joint.

Authors:  Anthony E Johnson; Mark R Bagg
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2005-05

2.  Closed complex dorsal dislocation of the middle finger metacarpophalangeal joint: anatomic considerations and treatment.

Authors:  J W May; R J Rohrich; J Sheppard
Journal:  Plast Reconstr Surg       Date:  1988-10       Impact factor: 4.730

3.  Complex dislocation of the metacarpophalangeal joint of the index finger with sesamoid entrapment.

Authors:  D Baltas
Journal:  Injury       Date:  1995-03       Impact factor: 2.586

4.  Open complex metacarpophalangeal joint dislocation. Two cases: index finger and long finger.

Authors:  J E Imbriglia; R Sciulli
Journal:  J Hand Surg Am       Date:  1979-01       Impact factor: 2.230

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.